share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:拟议出售证券
美股sec公告 ·  05/02 15:30
Moomoo AI 已提取核心信息
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 9,555 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $83,489, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 4,782 shares by the officer in the past three months, which had gross proceeds of $53,181.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 9,555 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $83,489, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 4,782 shares by the officer in the past three months, which had gross proceeds of $53,181.
根据最新文件,Arcutis Biotherapeutics, Inc.高管伯内特·帕特里克定于2024年2月5日出售9,555股普通股。这些股票的总市值为83,489美元,于2024年1月5日通过Arcutis Biotherapeutics的限制性股票背心收购。该交易是在该高管在过去三个月中出售了4,782股股票之后进行的,总收益为53,181美元。
根据最新文件,Arcutis Biotherapeutics, Inc.高管伯内特·帕特里克定于2024年2月5日出售9,555股普通股。这些股票的总市值为83,489美元,于2024年1月5日通过Arcutis Biotherapeutics的限制性股票背心收购。该交易是在该高管在过去三个月中出售了4,782股股票之后进行的,总收益为53,181美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息